Tanke Biosciences Corp (TNBI) stock
Close on Oct 19, 2026Market cap $399.72KP/E –Yield –
Tanke Biosciences Corp saw revenue fall 19.5% to $22.96M over the twelve months to Sep 30, 2013. Operating income fell 101.1% to -$57.27K, moving the operating margin from 18.2% to -0.2%. Free cash flow was -$6.13M, down 273.3% from a year earlier. At the latest close the market valued the company at $399.72K.
Key statistics
Valuation at the latest close; fundamentals over the trailing twelve months, balances at Sep 30, 2013
Valuation
- Market cap
- $399.72K
- P/E ratio
- –
- Price to sales
- 0.02
- Price to book
- 0.03
- Dividend yield
- –
- Free cash flow yield
- -1532.72%
Fundamentals
- Revenue
- $22.96M
- Net income
- -$1.64M
- EPS, diluted
- -$0.12
- Free cash flow
- -$6.13M
- Book value per share
- $1.17
- Diluted shares
- 13M
Trading
- Previous close
- $0.03
- Open
- $0.03
- Day's range
- $0.03 – $0.03
- Volume
- 0
Total return vs. the S&P 500
Price change plus reinvested dividends, to the close on Oct 19, 2026. The S&P 500 is measured by the SPY fund.
| Period | TNBI | S&P 500 | Difference | TNBI per year | S&P 500 per year |
|---|---|---|---|---|---|
| 1 month | +200.0% | +0.6% | +199.4 pts | ||
| 3 months | +50.0% | +3.4% | +46.6 pts | ||
| Year to date | +14.1% | +13.3% | +0.8 pts | ||
| 1 year | -40.0% | +16.6% | −56.6 pts | ||
| 3 years | -70.0% | +86.4% | −156.4 pts | -33.1% | +23.1% |
| 5 years | -97.3% | +81.9% | −179.2 pts | -51.6% | +12.7% |
| 10 years | +50.0% | +318.9% | −268.9 pts | +4.1% | +15.4% |
Four years at a glance
Fiscal years 2009 to 2012 and trailing twelve months, USD
Revenue
Gross profit
Operating income
Net income
EPS, diluted
Free cash flow
About Tanke Biosciences
Grain Mill Products
Tanke Biosciences Corporation develops, manufactures, and supplies animal nutrition products and feed additives. Its primary product lines include organic trace mineral additives, feed acidifiers, flavor enhancers and seasonings, and herbal medicinal additives, as well as water-soluble multi-vitamin electrolytes. These nutritional products are formulated to support the growth and health of livestock, such as swine, poultry, and cattle, in addition to farmed fish and seafood. The company serves major feed manufacturers, large-scale commercial farming operations, and smaller agricultural farms through regional and local distribution partners.
Company profile, executives and historyTanke Biosciences stock: common questions
What is Tanke Biosciences's stock price?
TNBI closed at $0.03 on Oct 19, 2026, up 0.00% on the day.
What is Tanke Biosciences's market cap?
Tanke Biosciences was worth $399.72K at the close on Oct 19, 2026: the share price times the diluted shares outstanding.
What is TNBI's P/E ratio?
Tanke Biosciences lost money over the twelve months to Sep 30, 2013 (diluted EPS -$0.12), so it has no meaningful P/E ratio.
How much revenue does Tanke Biosciences make?
Tanke Biosciences reported revenue of $22.96M for the twelve months to Sep 30, 2013, down 19.5% from a year earlier.
Does Tanke Biosciences pay a dividend?
No. Tanke Biosciences has not paid a cash dividend over the last twelve months.
How has TNBI stock performed over the past year?
Including dividends, TNBI returned -40.0% over the past year, against +16.6% for the S&P 500.
Who are Tanke Biosciences's competitors?
Companies most similar to Tanke Biosciences by business, industry and size include INGR, FRPT, AFRI, POST, UCFI.
See a number that looks wrong?